289 related articles for article (PubMed ID: 35093339)
1. Endothelial group IVA phospholipase A
Kawashita E; Ozaki T; Ishihara K; Kashiwada C; Akiba S
Life Sci; 2022 Apr; 294():120355. PubMed ID: 35093339
[TBL] [Abstract][Full Text] [Related]
2. Group IVA Phospholipase A
Kishinaka S; Kawashita E; Nishizaki T; Ishihara K; Akiba S
Biol Pharm Bull; 2024; 47(5):1058-1065. PubMed ID: 38825533
[TBL] [Abstract][Full Text] [Related]
3. Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis.
Guo Q; Furuta K; Islam S; Caporarello N; Kostallari E; Dielis K; Tschumperlin DJ; Hirsova P; Ibrahim SH
Front Immunol; 2022; 13():983255. PubMed ID: 36091042
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of Group IVA Phospholipase A
Akiba S; Kawashita E; Ishihara K
Yakugaku Zasshi; 2019; 139(9):1155-1162. PubMed ID: 31474631
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of Group IVA Phospholipase A
Ozaki T; Kawashita E; Ishihara K; Akiba S
Biol Pharm Bull; 2023; 46(3):488-493. PubMed ID: 36858578
[TBL] [Abstract][Full Text] [Related]
6. A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis.
Hammoutene A; Biquard L; Lasselin J; Kheloufi M; Tanguy M; Vion AC; Mérian J; Colnot N; Loyer X; Tedgui A; Codogno P; Lotersztajn S; Paradis V; Boulanger CM; Rautou PE
J Hepatol; 2020 Mar; 72(3):528-538. PubMed ID: 31726115
[TBL] [Abstract][Full Text] [Related]
7. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y
Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659
[TBL] [Abstract][Full Text] [Related]
8. Group IVA phospholipase A2 participates in the progression of hepatic fibrosis.
Ishihara K; Miyazaki A; Nabe T; Fushimi H; Iriyama N; Kanai S; Sato T; Uozumi N; Shimizu T; Akiba S
FASEB J; 2012 Oct; 26(10):4111-21. PubMed ID: 22750514
[TBL] [Abstract][Full Text] [Related]
9. [Dynamic observation on capillarization of liver sinusoidal endothelial cells induced by
Zhang R; Xie J; Wei F; Mo X; Song P; Cai Y; Lu Y; Sun J; Zhou Y; Lin L; Zhang T; Chen M
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Apr; 36(1):34-43. PubMed ID: 38604683
[TBL] [Abstract][Full Text] [Related]
10. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
[TBL] [Abstract][Full Text] [Related]
11. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
[TBL] [Abstract][Full Text] [Related]
12. The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
Bae CR; Zhang H; Kwon YG
PLoS One; 2020; 15(12):e0243497. PubMed ID: 33275637
[TBL] [Abstract][Full Text] [Related]
13. Notch-triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase.
Fang ZQ; Ruan B; Liu JJ; Duan JL; Yue ZS; Song P; Xu H; Ding J; Xu C; Dou GR; Wang L
Hepatology; 2022 Sep; 76(3):742-758. PubMed ID: 35006626
[TBL] [Abstract][Full Text] [Related]
14. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats.
Xie G; Wang X; Wang L; Wang L; Atkinson RD; Kanel GC; Gaarde WA; Deleve LD
Gastroenterology; 2012 Apr; 142(4):918-927.e6. PubMed ID: 22178212
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
Min-DeBartolo J; Schlerman F; Akare S; Wang J; McMahon J; Zhan Y; Syed J; He W; Zhang B; Martinez RV
PLoS One; 2019; 14(12):e0226854. PubMed ID: 31891606
[TBL] [Abstract][Full Text] [Related]
16. Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells.
Wu X; Shu L; Zhang Z; Li J; Zong J; Cheong LY; Ye D; Lam KSL; Song E; Wang C; Xu A; Hoo RLC
Adv Sci (Weinh); 2021 Jun; 8(11):e2003721. PubMed ID: 34105268
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic alpha-7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non-alcoholic steatohepatitis.
Kimura K; Inaba Y; Watanabe H; Matsukawa T; Matsumoto M; Inoue H
J Diabetes Investig; 2019 May; 10(3):659-666. PubMed ID: 30369082
[TBL] [Abstract][Full Text] [Related]
18. The protective effects of Ninjin'yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse.
Takano K; Kaneda M; Aoki Y; Fujita N; Chiba S; Michihara S; Han LK; Takahashi R
J Nat Med; 2024 Jun; 78(3):514-524. PubMed ID: 38498120
[TBL] [Abstract][Full Text] [Related]
19. ASB14780, an Orally Active Inhibitor of Group IVA Phospholipase A2, Is a Pharmacotherapeutic Candidate for Nonalcoholic Fatty Liver Disease.
Kanai S; Ishihara K; Kawashita E; Tomoo T; Nagahira K; Hayashi Y; Akiba S
J Pharmacol Exp Ther; 2016 Mar; 356(3):604-14. PubMed ID: 26699145
[TBL] [Abstract][Full Text] [Related]
20. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease.
Hammoutene A; Rautou PE
J Hepatol; 2019 Jun; 70(6):1278-1291. PubMed ID: 30797053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
